Clinical Trial Update: Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two doses of tiotropium Respimat with placebo as add-on therapy in children with moderate persistent asthma to assess efficacy and saf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tiotropium Respimat (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2016-07-12